Portfolio (Quarterly)
Guide ↗
Tetragon Partners GP Ltd
· CIK 0001515070| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 201,036.0 | $7.3M | 1.15% | NEW | — | $36.41 | +4.8% |
| 22 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 19,668.0 | $7.3M | 1.15% | NEW | — | $371.67 | -6.8% |
| 23 | ANNX | ANNEXON INC | Healthcare | 1,242,455.0 | $7.1M | 1.12% | NEW | — | $5.71 | -11.2% |
| 24 | CELC | CELCUITY INC | Healthcare | 64,110.0 | $6.7M | 1.06% | NEW | — | $104.62 | -10.6% |
| 25 | WBD | WARNER BROS DISCOVERY INC | Communication Services | 250,000.0 | $6.7M | 1.05% | NEW | — | $26.66 | +7.1% |
| 26 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 86,996.0 | $6.1M | 0.96% | NEW | — | $69.81 | +6.0% |
| 27 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 297,926.0 | $5.4M | 0.84% | NEW | — | $17.96 | +115.3% |
| 28 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 167,875.0 | $4.2M | 0.67% | NEW | — | $25.30 | +16.6% |
| 29 | RARE CALL | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 100,000.0 | $3.3M | 0.53% | NEW | — | $33.39 | -22.6% |
| 30 | SLN CALL | SILENCE THERAPEUTICS PLC | Healthcare | 300,000.0 | $3.3M | 0.52% | NEW | — | $10.98 | +20.9% |
| 31 | CUE | CUE BIOPHARMA INC | Healthcare | 93,819.0 | $3.0M | 0.47% | NEW | — | $31.56 | -24.0% |
| 32 | SNOW | SNOWFLAKE INC | Technology | 10,000.0 | $2.5M | 0.40% | NEW | — | $254.50 | +30.8% |
| 33 | KPTI CALL | KARYOPHARM THERAPEUTICS INC | Healthcare | 250,300.0 | $2.4M | 0.39% | NEW | — | $9.77 | -79.9% |
| 34 | ACRS | ACLARIS THERAPEUTICS INC | Healthcare | 400,000.0 | $2.1M | 0.33% | NEW | — | $5.29 | +21.2% |
| 35 | AGIO CALL | AGIOS PHARMACEUTICALS INC | Healthcare | 50,000.0 | $1.9M | 0.29% | NEW | — | $37.11 | -10.8% |
| 36 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 46,516.0 | $1.6M | 0.25% | NEW | — | $34.38 | +9.5% |
| 37 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 56,052.0 | $1.4M | 0.21% | NEW | — | $24.20 | -40.9% |
| 38 | — CALL | TENAX THERAPEUTICS INC | — | 75,100.0 | $1.1M | 0.17% | NEW | — | $14.55 | — |
| 39 | AMLX CALL | AMYLYX PHARMACEUTICALS INC | Healthcare | 8,500.0 | $153K | 0.02% | NEW | — | $17.96 | +115.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
66.8%
Healthcare
32.0%
Communication Services
1.1%